Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide in Idiopathic Retroperitoneal Fibrosis
NCT04762810Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2020
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cyclophosphamide in Idiopathic retroperitoneal fibrosis (RPF) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: remission at 5 years. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
Idiopathic retroperitoneal fibrosis (RPF)
Beyond the preview
Go deeper on NCT04762810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762810.